RU94014833A - Agent for treatment of articular and periarticular tissue degenerative diseases
- Google Patents
Agent for treatment of articular and periarticular tissue degenerative diseases
Info
Publication number
RU94014833A
RU94014833ARU94014833/14ARU94014833ARU94014833ARU 94014833 ARU94014833 ARU 94014833ARU 94014833/14 ARU94014833/14 ARU 94014833/14ARU 94014833 ARU94014833 ARU 94014833ARU 94014833 ARU94014833 ARU 94014833A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ю.А. Трубенко, А.Р. Бабаева, А.С. Чернов, Б.А. Лемперт, А.Б. ЗборовскийfiledCriticalЮ.А. Трубенко
Priority to RU94014833ApriorityCriticalpatent/RU2085194C1/en
Publication of RU94014833ApublicationCriticalpatent/RU94014833A/en
Application grantedgrantedCritical
Publication of RU2085194C1publicationCriticalpatent/RU2085194C1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
FIELD: medicine, rheumatology. SUBSTANCE: treatment involves the use of combined action of antiinflammatory agent (sodium diclofenac), glycosaminoglycane-polysulfate and dimethylsulfoxide. Agent is applied on the skin over the damaged site, 2-3 times per a day. Treatment course is 3-4 weeks. Proposed agent shows chondroprotective effect. EFFECT: enhanced effectiveness, relapse prevention.
Claims (1)
Изобретение относится к медицине, а именно - к ревматологии, и предназначено для местного лечения дегенеративных заболеваний и околосуставных мягких тканей. Целью изобретения является повышение эффективности противовоспалительного воздействия, предупреждения рецидивов заболевания за счет хондропротекторного эффекта. Указанная цель достигается комбинированным воздействием противовоспалительного препарата (диклофенака-натрия), гликозаминогликана-полисульфата и диметилсульфоксида. Средство наносят на кожу над участком поражения 2 - 3 раза в день. Курс лечения 3 - 4 недели.The invention relates to medicine, namely to rheumatology, and is intended for local treatment of degenerative diseases and periarticular soft tissues. The aim of the invention is to increase the effectiveness of anti-inflammatory effects, preventing relapse of the disease due to the chondroprotective effect. This goal is achieved by the combined effect of an anti-inflammatory drug (diclofenac-sodium), glycosaminoglycan-polysulfate and dimethyl sulfoxide. The product is applied to the skin over the lesion 2 to 3 times a day. The course of treatment is 3 to 4 weeks.
RU94014833A1994-04-211994-04-21Agent for local application
RU2085194C1
(en)
Compound, pharmaceutical composition and process for the treatment of an inflammatory disease susceptible to treatment with a non-toxic non-steroidal anti-inflammatory agent, pharmaceutically acceptable salt, use of a compound
DIAROMATIC COMPOUNDS PROPINIL OR DIENIL, INTERMEDIATE CONNECTIONS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON THE SPECIFIED CONNECTIONS AND APPLICATION OF COSMETIC COMPOSITIONS